Markets:

Overview

News

Currencies

International

Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

2.520 +0.090 (+3.70%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 11, 2024

Via Benzinga

Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday ↗

October 11, 2024

Via Benzinga

A Biotech Breakout Will Be Led By Small Caps ↗

September 23, 2024

It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.

Via Talk Markets

Topics Artificial Intelligence Economy

Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday ↗

September 06, 2024

Via Benzinga

What 5 Analyst Ratings Have To Say About Pacific Biosciences ↗

August 28, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Pacific Biosciences ↗

August 12, 2024

Via Benzinga

Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

August 16, 2024

Via Benzinga

Peering Into Pacific Biosciences's Recent Short Interest ↗

August 08, 2024

Via Benzinga

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024 ↗

August 07, 2024

PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm

August 02, 2024

From The Schall Law Firm

Via Business Wire

Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices

June 27, 2024

Via ACCESSWIRE

How Is The Market Feeling About Pacific Biosciences? ↗

May 22, 2024

Via Benzinga

Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts ↗

May 13, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Pacific Biosciences Through 4 Analysts ↗

April 17, 2024

Via Benzinga

Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday? ↗

July 16, 2024

Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in...

Via Benzinga

Topics Economy Stocks

Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 16, 2024

Via Benzinga

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday ↗

July 16, 2024

Via Benzinga

Strategic Buy Lights Up This Biotech Stock: Time to Invest?

July 16, 2024

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Via MarketBeat

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday ↗

July 11, 2024

Via Benzinga

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns ↗

June 13, 2024

Jefferies Financial Group sees these three companies as prime candidates among stocks for double-digit returns.

Via InvestorPlace

Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know ↗

June 03, 2024

Via Benzinga

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗

May 28, 2024

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

Via Benzinga

Topics ETFs

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 14, 2024

Via Benzinga

Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday ↗

May 14, 2024

Via Benzinga

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session ↗

May 06, 2024

Via Benzinga

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday ↗

April 26, 2024

Via Benzinga

Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket ↗

April 17, 2024

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.